Literature DB >> 25421799

Reimbursement in molecular pathology: bringing genomic medicine to patients.

Roger D Klein1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25421799     DOI: 10.1373/clinchem.2014.223032

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  4 in total

1.  Validation of Molecular Pathology Codes for the Identification of Mutational Testing in Lung and Colon Cancer.

Authors:  Anil Vachani; Yu-Ning Wong; Jennifer Israelite; Nandita Mitra; Sakhena Hin; Lin Yang; Aaron Smith-McLallen; Katrina Armstrong; Peter W Groeneveld; Andrew J Epstein
Journal:  Med Care       Date:  2017-12       Impact factor: 2.983

2.  Integrating pharmacogenetic testing into primary care.

Authors:  Susanne B Haga
Journal:  Expert Rev Precis Med Drug Dev       Date:  2017-11-03

3.  Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options.

Authors:  Rositsa Koleva-Kolarova; James Buchanan; Heleen Vellekoop; Simone Huygens; Matthijs Versteegh; Maureen Rutten-van Mölken; László Szilberhorn; Tamás Zelei; Balázs Nagy; Sarah Wordsworth; Apostolos Tsiachristas
Journal:  Appl Health Econ Health Policy       Date:  2022-04-04       Impact factor: 3.686

4.  Genetic testing utilization for patients with neurologic disease and the limitations of claims data.

Authors:  Samuel J Mackenzie; Chun Chieh Lin; Peter K Todd; James F Burke; Brian C Callaghan
Journal:  Neurol Genet       Date:  2020-02-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.